Skip Navigation
The Collection >
Heparin: improving treatment and reducing risk of harm.
Daner WE, Gosselin RC, Raschke R, Vanderveen T. Patient Saf Qual Healthcare. January/February 2009;6:20-25.

This article explains safety challenges commonly associated with heparin, a high-alert medication, and outlines how hospitals and clinicians can prevent these errors.
Free full text icon indicating hyperlink to external website
white box
Related Resources
COMMENTARY
Improving heparin safety: a multidisciplinary invited conference.
Peterson C, Ham CW, Vanderveen T. Hosp Pharm. 2008;43:491-497.
NEWSPAPER/MAGAZINE ARTICLE
Collaboration focused on priority issues promotes safety.
ISMP Medication Safety Alert! Acute Care Edition. October 10, 2008;13:1-3.
STUDY
Adverse drug events among hospitalized Medicare patients: epidemiology and national estimates from a new approach to surveillance.
Classen DC, Jaser L, Budnitz DS. Jt Comm J Qual Patient Saf. 2010;36:12-21, AP1-AP9.
COMMENTARY
ISMP medication error report analysis.
Cohen MR, Smetzer JL. Hosp Pharm. 2010;45:191-195.
View all related resources...
white box
Download: Adobe Reader   email icon Email
tan box
white box